Validus Pharmaceuticals is a leading pharmaceutical company. It focused on acquiring, reformulating, and marketing prescription medications in specialty therapeutic areas. The business of this company is based on the acquisition of established products that are FDA-approved and satisfy unmet clinical needs.

Validus Pharmaceuticals welcomes inquiries from business development executives who would like to derive value from their well-known brands through licensing partnerships. It addresses all business development inquiries to John Kinney, CEO.

Validus Pharmaceuticals has coordinated with the U.S. Food and Drug Administration (FDA) to form Marplan available to people in the U.S. who are in desperate need of relief from their illness. The trusted company has imported another manufacturer’s Marplan for the U.S. market. This medical solution is manufactured and marketed in Denmark by MediLink.

Validus Pharmaceuticals is a Parsippany, New Jersey-based specialty pharmaceutical company, which provides FDA-approved prescription products that satisfy unmet medical needs.  It strives to fulfill its mission; the company seeks out and acquires marketed products that have well-established safety profiles as well as significant clinical benefits.